| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Common Stock | Options Exercise | $745,675 | +17,500 | +4.2% | $42.61 | 436,838 | 29 Nov 2021 | Direct | F1, F2 |
| transaction | CRI | Common Stock | Sale | $1,826,125 | -17,500 | -4% | $104.35 | 419,338 | 29 Nov 2021 | Direct | F1, F2, F3 |
| transaction | CRI | Common Stock | Sale | $1,330,812 | -12,600 | -3% | $105.62 | 406,738 | 29 Nov 2021 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -17,500 | -100% | $0.000000* | 0 | 29 Nov 2021 | Common Stock | 17,500 | $42.61 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The transaction reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan |
| F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
| F3 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $103.50 to $105.35 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F4 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $105.15 to $106.00 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F5 | The option vested in four equal installments on February 22, 2013, 2014, 2015, and 2016. |